| Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide CG Kanakry, J Bolaños-Meade, YL Kasamon, M Zahurak, N Durakovic, ... Blood, The Journal of the American Society of Hematology 129 (10), 1389-1393, 2017 | 79 | 2017 |
| Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic … P Dreger, M Michallet, P Bosman, S Dietrich, M Sobh, A Boumendil, ... Bone marrow transplantation 54 (1), 44-52, 2019 | 71 | 2019 |
| Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis N Durakovic, V Radojcic, A Boban, M Mrsic, D Sertic, R Serventi-Seiwerth, ... Internal medicine 50 (9), 1009-1013, 2011 | 56 | 2011 |
| Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions N Durakovic, KB Bezak, M Skarica, V Radojcic, EJ Fuchs, GF Murphy, ... The Journal of Immunology 177 (7), 4414-4425, 2006 | 50 | 2006 |
| Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation Z Peric, J Wilson, N Durakovic, A Ostojic, L Desnica, VR Vranjes, ... Bone Marrow Transplantation 53 (11), 1450-1456, 2018 | 41 | 2018 |
| Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse N Durakovic, V Radojcic, M Skarica, KB Bezak, JD Powell, EJ Fuchs, ... Blood 109 (10), 4564-4574, 2007 | 39 | 2007 |
| Influence of blood count, cardiovascular risks, inherited thrombophilia, and JAK2 V617F burden allele on type of thrombosis in patients with Philadelphia chromosome negative … I Horvat, A Boban, R Zadro, MR Antolic, R Serventi-Seiwerth, P Roncevic, ... Clinical Lymphoma Myeloma and Leukemia 19 (1), 53-63, 2019 | 32 | 2019 |
| Amniotic membrane transplantation—a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease Z Peric, I Skegro, N Durakovic, L Desnica, D Pulanic, R Serventi-Seiwerth, ... Bone Marrow Transplantation 53 (11), 1466-1469, 2018 | 28 | 2018 |
| HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse MB Kamenaric, M Maskalan, Z Grubic, M Mikulic, RS Seiwerth, ... Human immunology 78 (11-12), 665-671, 2017 | 17 | 2017 |
| Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre-and post-transplantation cyclophosphamide LR Lombardi, CG Kanakry, M Zahurak, N Durakovic, J Bolaños-Meade, ... Leukemia & lymphoma 57 (3), 666-675, 2016 | 15 | 2016 |
| Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity N Durakovic, V Radojcic, J Powell, L Luznik Transplantation 83 (5), 631-640, 2007 | 14 | 2007 |
| Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia M Michallet, P Dreger, M Sobh, L Koster, J Hoek, A Boumendil, C Scheid, ... Bone marrow transplantation 55 (5), 884-890, 2020 | 13 | 2020 |
| Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study I Aurer, N Durakovic, I Radman, D Nemet, S Zupancic-Salek, ... Croatian medical journal 43 (5), 550-554, 2002 | 13 | 2002 |
| Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease? Z Perić, L Desnica, N Duraković, A Ostojić, D Pulanić, R Serventi-Seiwerth, ... Croatian Medical Journal 57 (1), 6-15, 2016 | 12 | 2016 |
| Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant S Bašić Kinda, N Duraković, S Dotlić, R Serventi Seiwerth, ... Leukemia & lymphoma 54 (6), 1334-1335, 2013 | 12 | 2013 |
| Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease D Ljubas Kelecic, A Lelas, I Karas, L Desnica, T Vukic, I Sabol, ... Journal of cancer research and clinical oncology 146, 2967-2978, 2020 | 9 | 2020 |
| Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera I Krečak, M Lucijanić, V Gverić-Krečak, N Duraković Leukemia & lymphoma 61 (7), 1744-1747, 2020 | 8 | 2020 |
| Ibrutinib for bridging to allogeneic hematopoietic stem cell transplantation (alloHCT) in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) is safe and … P Dreger, M Michallet, J Hoek, A Boumendil, M Sobh, L Muller, ... Blood 128 (22), 4657, 2016 | 8 | 2016 |
| Serum chitotriosidase: a circulating biomarker in polycythemia vera I Krecak, V Gveric-Krecak, P Roncevic, S Basic-Kinda, J Gulin, I Lapic, ... Hematology 23 (10), 793-802, 2018 | 7 | 2018 |
| Salvage use of ibrutinib after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for B cell malignancies: a study of the French Cooperative Group for CLL, the … M Michallet, P Dreger, M Sobh, J Hoek, A Boumendil, L Muller, ... Blood 128 (22), 4659, 2016 | 7 | 2016 |
Radovan VrhovacFull Professor Tenure, Department of Medicine, University of Zagreb School of MedicineVerified email at mef.hr
